. 2021 May 11;259(9):2731–2741. doi: 10.1007/s00417-021-05203-2

Table 2.

Retinal thickness in μm and best spectacle-corrected visual acuity in logMAR at various time points in uncomplicated Descemet membrane endothelial keratoplasty without macular edema and uncomplicated Descemet membrane endothelial keratoplasty with macular edema

		Pre-surgery	1 week postop	1 month postop	6 months postop
RT in DMEK without DMEK-ME [in μm]	CSF	280.8 ± 19.8 (251-315)	285.0 ± 24.2 (241-320)	283.7 ± 22.2 (235-314)	283.3 ± 20.8 (235-315)
3 mm subfield	339.2 ± 13.3 (322.75-365.25)	344.8 ± 12.8 (327-365.75)	348.6 ± 16.1 (327-375.5)	343.0 ± 16.5 (318.75-376)
6 mm subfield	295.8 ± 11.2 (280-309)	301.9 ± 13.1 (276.5-315.75)	303.3 ± 13.0 (276.5-318.5)	300.3 ± 14.3 (273-318.75)
BSCVA in DMEK without DMEK-ME [in logMAR]		0.77 ± 0.86 (2-0.4)	0.6 ± 0.74 (1.3-0.22)	0.23 ± 0.87 (0.4-0.0)	0.13 ± 0.72 (0.4-0.0)
RT in DMEK-ME [in μm]	CSF	294.0 ± 14.9 (271-313) P = 0.058	299.7 ± 14.3 (276-311) P = 0.086	432.0 ± 97.6 * (355-583) P = 0.01	297.5 ± 24.3 (264-325) P = 0.129
3 mm subfield	342.3 ± 13.0 (320-361.3) P = 0.355	330.4 ± 11.6 (306.5-344.25) P = 0.064	384.0 ± 41.4 (350-447.5) P = 0.06	348.2 ± 28.8 (276-311) P = 0.365
6 mm subfield	299.2 ± 8.2 (288-314) P = 0.287	292.6 ± 5.0 (286.5-297.5) P = 0.094	317.0 ± 19.7 (290.5-340.25) P = 0.109	300.8 ± 17.0 (275.0-324.25) P = 0.480
BSCVA in DMEK-ME [in logMAR]		0.69 ± 0.87 (2-0.4) P = 0.244	0.7 ± 1.1 (1.3-0.52) P = 0.139	0.38 ± 0.92 (0.7-0.3) * P = 0.015	0.14 ± 0.69 (0.4-0.0) P = 0.397

Pre-surgery

1 week postop

1 month postop

6 months postop

RT in DMEK without DMEK-ME [in μm]

CSF

280.8 ± 19.8

(251-315)

285.0 ± 24.2

(241-320)

283.7 ± 22.2

(235-314)

283.3 ± 20.8

(235-315)

3 mm subfield

339.2 ± 13.3

(322.75-365.25)

344.8 ± 12.8

(327-365.75)

348.6 ± 16.1

(327-375.5)

343.0 ± 16.5

(318.75-376)

6 mm subfield

295.8 ± 11.2

(280-309)

301.9 ± 13.1

(276.5-315.75)

303.3 ± 13.0

(276.5-318.5)

300.3 ± 14.3

(273-318.75)

BSCVA in DMEK without DMEK-ME [in logMAR]

0.77 ± 0.86 (2-0.4)

0.6 ± 0.74 (1.3-0.22)

0.23 ± 0.87 (0.4-0.0)

0.13 ± 0.72 (0.4-0.0)

RT in DMEK-ME [in μm]

CSF

294.0 ± 14.9

(271-313)

P = 0.058

299.7 ± 14.3

(276-311)

P = 0.086

432.0 ± 97.6 *

(355-583)

P = 0.01

297.5 ± 24.3

(264-325)

P = 0.129

3 mm subfield

342.3 ± 13.0

(320-361.3)

P = 0.355

330.4 ± 11.6

(306.5-344.25)

P = 0.064

384.0 ± 41.4

(350-447.5)

P = 0.06

348.2 ± 28.8

(276-311)

P = 0.365

6 mm subfield

299.2 ± 8.2

(288-314)

P = 0.287

292.6 ± 5.0

(286.5-297.5)

P = 0.094

317.0 ± 19.7

(290.5-340.25)

P = 0.109

300.8 ± 17.0

(275.0-324.25)

P = 0.480

BSCVA in DMEK-ME [in logMAR]

0.69 ± 0.87 (2-0.4)

P = 0.244

0.7 ± 1.1 (1.3-0.52)

P = 0.139

0.38 ± 0.92 (0.7-0.3) *

P = 0.015

0.14 ± 0.69 (0.4-0.0)

P = 0.397

RT retinal thickness, DMEK Descemet membrane endothelial keratoplasty, DMEK-ME macular edema after uncomplicated Descemet membrane endothelial keratoplasty. CSF central subfield, corresponding to the 1 mm Early Treatment Diabetic Retinopathy Study (EDTRS) subfield of the retinal thickness map of the HRA/Spectralis Viewing Module (Heidelberg Eye Explorer, Heidelberg Engineering, Heidelberg, Germany); 3 mm subfield = 3 mm ETDRS subfield; 6 mm subfield = 6 mm ETDRS subfield. BSCVA best spectacle-corrected visual acuity, logMAR logarithm of minimal angle of resolution

RT and BSCVA in DMEK-ME compared to RT in DMEK without DMEK-ME. * = P < 0.05